An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open‐label multicenter clinical study

PURPOSE: To assess the efficacy and safety of dydrogesterone in Japanese women with ovarian endometrioma in a real‐world setting. METHODS: The post‐marketing study involved 15 sites in Japan. Dydrogesterone 10 mg twice daily orally was administered for 21 days (day 5‐25 of each menstrual cycle) for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitawaki, Jo, Koga, Kaori, Kanzo, Takumi, Momoeda, Mikio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254175/
https://www.ncbi.nlm.nih.gov/pubmed/34262403
http://dx.doi.org/10.1002/rmb2.12391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254175/
https://www.ncbi.nlm.nih.gov/pubmed/34262403
http://dx.doi.org/10.1002/rmb2.12391

Ejemplares similares